Strategic Partnerships Expression Therapeutics has established a collaboration with Stanford Medicine, indicating a strong focus on innovative research and potential for joint development opportunities in advanced gene and cell therapies.

Facility Expansion The company has recently expanded its manufacturing capabilities in Ohio with state-of-the-art 43,000 square foot facilities in Cincinnati and Butler County, reflecting a readiness to scale production and meet growing clinical trial demands.

Technology Infrastructure With a modern tech stack including cloud-based CDN, PWA, and secure protocols, Expression Therapeutics maintains a robust digital infrastructure, opening opportunities for partnerships in digital health, data management, and cloud services.

Financial Position Operating within the $10M to $25M revenue range, the company demonstrates stable financial footing with ongoing investments in infrastructure and R&D, offering prospects for technology providers and financial services tailored for biotech growth.

Market Focus Specializing in hematology and oncology therapeutics, especially gene therapies like liver-targeting hemophilia treatments, positions Expression Therapeutics as a prime candidate for suppliers of specialized biotech equipment, raw materials, and clinical services.